| J9271 | Injection, pembrolizumab, 1 mg | 12,200 | $40 | $524.6K |
| J0897 | Injection, denosumab, 1 mg | 6,420 | $20 | $115.6K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 550 | $90 | $51.9K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 340 | $100 | $33.6K |
| J0881 | Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 11,970 | $1 | $23.9K |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | 90 | $130 | $11.4K |
| 96365 | The provider administers the initial intravenous infusion of a medication or other substance for a period up to one hour to prevent, treat, or diagnose a condition or disease. | 170 | $50 | $8.2K |
| 99204 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider… | 60 | $120 | $7.6K |
| 96401 | The provider administers nonhormonal, antineoplastic chemotherapy drugs subcutaneously or intramuscularly to the patient. | 120 | $60 | $6.7K |
| 96375 | Following the administration of a drug or other substance via intravenous, or IV, push, the provider sequentially infuses a different medication or medications, also via IV push. He administers the… | 500 | $10 | $6K |